Prognostic value of PSMA PET in predicting long-term biochemical control following curative intent treatment for prostate cancer.

• Tác giả: Angus Ades, Tanya Holt, Ahmed M Mehdi, Gishan Ratnayake, Handoo Rhee, Myles Webb
• Ngôn ngữ: eng
• Ký hiệu phân loại: 004.2 Systems analysis and design, computer architecture, performance evaluation
• Thông tin xuất bản: Australia : Journal of medical imaging and radiation oncology , 2025
• Bộ sưu tập: NCBI
• ID: 175547

Tóm tắt

INTRODUCTION: The aim of this study is to investigate the prognostic value of METHODS: We completed a prospective study that followed men who had PSMA PET for staging of newly diagnosed prostate cancer between 2015 and 2017 who went on to have curative intent treatment with radiotherapy (RT) or radical prostatectomy (RP). PSMA PET CT imaging was reported and the intraprostatic maximum standardised uptake value (SUV RESULTS: A total of 183 men were included in the analysis with a median age of 66 years and the majority of patients (55.2%) had ISUP grade 1-3 disease. All patients had PSMA PET staging prior to curative intent treatment with RP (66.1%) or external beam radiotherapy (33.9%). PSMA-avid pelvic nodes were present in 26 patients but were not associated with worse biochemical control. A PSMA SUV CONCLUSION: PSMA SUV